May 22, 2024
Saliva Collection Devices Market

Saliva Collection Devices Market are Transforming Oral Fluid Testing Market with Advancements in Molecular Diagnostics and Remote Patient Monitoring

Saliva collection devices help in collecting saliva samples for various diagnostic purposes including molecular diagnostics, patient monitoring, and disease screening among others. Saliva collection devices are available in different formats like solo cup, swab, and spit kits. They offer advantages like non-invasive & painless sample collection, ease of self-collection, and accurate results. Rising demand for non-invasive testing methods and advancements in molecular diagnostics are key growth drivers of this market.

Global Saliva Collection Devices Market is estimated to be valued at US$ 342.46 Bn in 2024 and is expected to exhibit a CAGR of 10% over the forecast period from 2024 to 2031.

The market is witnessing strong growth on account of increasing use of saliva testing in molecular diagnostic applications and monitoring of chronic diseases. Advancements in molecular diagnostic methods have enabled detection of multiple biomarkers and metabolites in saliva samples. This has augmented the use of saliva collection devices in applications ranging from cancer screening to health & wellness monitoring. Furthermore, non-invasive sample collection through saliva makes testing more patient-friendly.

Key Takeaways
Key players operating in the saliva collection devices are IBM Corporation, Oracle Corporation, Cerner Corporation, InterSystems Corporation, Allscripts Healthcare Solutions, Red Hat, Inc. (acquired by IBM), Microsoft Corporation, GE Healthcare, Infor, Inc., Epic Systems Corporation, TIBCO Software Inc., McKesson Corporation, Dell Technologies, Informatica Corporation, Ascom Holding AG.
Growing adoption of molecular diagnostic techniques for detection of chronic diseases such as COVID-19, cancer, diabetes etc. has propelled the demand for effective saliva collection devices. Availability of self-contained and easy to use collection devices is spurring their uptake in remote patient monitoring applications.
North America dominates the global market owing to rising investments in healthcare IT and increasing preference for non-invasive diagnostic techniques. However, Asia Pacific is expected to witness highest growth during the forecast period driven by growing medical tourism, increasing healthcare expenditure and expansion of private healthcare facilities.

Market Key Trends
Rise in demand for non-invasive testing is a major trend driving the Saliva Collection Devices Market Size. Traditional swab-based methods can cause discomfort and are prone to errors. Saliva collection devices provide pain-free alternatives to gather molecular-level patient data. With ongoing R&D in molecular diagnostics, saliva is emerging as an attractive biofluid for detecting multiple biomarkers simultaneously. This is propelling innovation of advanced collection technologies that can stabilize biomarkers in saliva for sensitive downstream analysis. Going forward, integration of IoT and connectivity features is expected to transform saliva collection devices into smart biosensors for continuous health monitoring applications.

Porter’s Analysis

Threat of new entrants: The capital requirements and regulatory barriers reduces the threat of new entrants.

Bargaining power of buyers: The buyers have moderate bargaining power as there are many established players in the market.

Bargaining power of suppliers: The suppliers have low to moderate bargaining power due to the fragmented nature of parts and raw material supply market.

Threat of new substitutes: There is limited threat from new substitutes due to specialized nature and regulatory requirements.

Competitive rivalry: The rivalry is high among the large established players.

Geographical Regions

North America holds the major share of the Saliva Collection Devices Market, both in terms of value and volume. United States leads the market in this region owing to well developed healthcare infrastructure, presence of major players, and higher healthcare spending.

Asia Pacific is expected to witness the fastest growth during the forecast period owing to increasing healthcare expenditure, large patient pool, and growing awareness about saliva testing. Rising geriatric population and increasing investment in healthcare infrastructure development are also driving the market growth in Asia Pacific region.

*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it